MetaCap

Kyntra Bio (KYNB) News

NASDAQ: KYNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.56-0.24 (-13.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KYNB news summary

We found 4 recent headlines mentioning Kyntra Bio (KYNB): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. KYNB is making an outsized move today, down 13.33% at $1.56, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Kyntra Bio (KYNB) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Kyntra Bio headlines

Stocks mentioned alongside KYNB

Compare KYNB